Our locations are open for appointments and procedures. See how we're providing safe in-person care and telemedicine visits.

(Nuestras facilidades están abiertas para citas y procedimientos. Vea cómo brindamos atención segura en persona y visitas por medio de telemedicina.)
 

Learn More (Aprenda Más)
Search temple health
EXPLORE TEMPLEHEALTH.ORG
ADDITIONAL LINKS

Neurosciences Center

800-TEMPLE-MED Schedule Appointment
SEARCH TEMPLE HEALTH
Neurosciences Center

A Study to Evaluate XEN1101 as Adjunctive Therapy in Focal Epilepsy

view all Clinical Trials

Overview

The XEN1101 Phase 2 clinical trial is a randomized, double-blind, placebo-controlled study that will evaluate the clinical efficacy, safety and tolerability of increasing doses of XEN1101 administered as adjunctive treatment in adult patients diagnosed with focal epilepsy

Clinical Trial Information

Protocol

WIRB# 20190479 NCT03796962

Phase

2

Condition(s)

Epilepsy and Seizures

Investigator

Mercedes Jacobson, MD

Coordinator

Theresa Ropars, RN
215-707-5440

Visit clinicaltrials.gov for full description.

Contact

For more information about this trial or to inquire about eligibility, call 215-707-5440 or email theresa.ropars@tuhs.temple.edu.

Full Title

A Randomized, Double Blind, Placebo Controlled, Multicenter Study to Evaluate the Safety, Tolerability and Efficacy of XEN1101 as Adjunctive Therapy in Focal Onset Epilepsy